COM:ASCENDISPHARMA
Ascendis Pharma
- Stock
Last Close
122.64
22/11 21:00
Market Cap
7.78B
Beta: -
Volume Today
378.33K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | 4.08M - | -9.66M 336.77% | -32.92M 240.88% | -68.50M 108.08% | -123.90M 80.86% | -130.10M 5.00% | -218.02M 67.58% | -418.95M 92.17% | -383.58M 8.44% | -583.19M 52.04% | -481.45M 17.45% | |
depreciation and amortization | 405K - | 504K 24.44% | 558K 10.71% | 677K 21.33% | 734K 8.42% | 880K 19.89% | 6.69M 660.11% | 9.45M 41.25% | 15.39M 62.90% | 17.96M 16.68% | 18.91M 5.31% | |
deferred income tax | 626K - | -682K 208.95% | -652K 4.40% | -227K 65.18% | -477K 110.13% | -394K 17.40% | -234K 40.61% | -219K 6.41% | -367K 67.58% | 5.38M 1,565.12% | 7.30M 35.82% | |
stock based compensation | 671K - | 1.27M 89.87% | 1.71M 34.46% | 7.32M 327.38% | 9.71M 32.62% | 19.65M 102.41% | 37.49M 90.75% | 53.17M 41.84% | 66.83M 25.69% | 64.18M 3.97% | 66.66M 3.86% | |
change in working capital | 525K - | -7.40M 1,510.29% | -4.66M 37.07% | 4.07M 187.29% | 5.02M 23.43% | 1.71M 66.02% | 4.07M 138.57% | -964K 123.69% | -48.91M 4,974.07% | -18.62M 61.94% | -99.79M 435.99% | |
accounts receivables | 4.01M - | 413K 89.71% | 228K 44.79% | 777K 240.79% | 99K 87.26% | 182K 83.84% | -1.87M 1,128.33% | -1.86M 0.64% | -6.92M 272.36% | -11.32M 63.52% | -32.10M 183.50% | |
inventory | 140K - | -766K 647.14% | -3.33M 334.33% | 1.55M 146.74% | -5.71M 467.52% | -5.64M - | -5.49M 2.68% | -75.41M 1,274.54% | -55.27M 26.71% | -78.26M 41.60% | ||
accounts payables | -12K - | 2.62M 21,950% | 3.40M 29.79% | 4.71M 38.44% | 10.76M 128.30% | 8.26M 23.18% | 7.51M 9.12% | 7.35M 2.17% | 40.75M 454.75% | 45.12M 10.72% | 3.48M 92.29% | |
other working capital | -3.48M - | -10.44M 200.32% | -8.29M 20.59% | -1.42M 82.86% | -5.83M 310.56% | -6.74M 15.50% | 4.07M 160.40% | -964K 123.69% | -7.33M 660.74% | 2.86M 138.98% | 7.09M 148.18% | |
other non cash items | 4K - | -2.44M 61,025% | -7.50M 207.92% | -3.51M 53.20% | 13.81M 493.28% | -30.55M 321.18% | -5.93M 80.59% | 85.97M 1,549.54% | -67.01M 177.95% | 18.60M 127.75% | 21.00M 12.91% | |
net cash provided by operating activities | 6.31M - | -18.40M 391.65% | -43.47M 136.19% | -60.18M 38.45% | -95.10M 58.03% | -138.80M 45.96% | -175.94M 26.75% | -271.55M 54.34% | -417.65M 53.80% | -495.70M 18.69% | -467.36M 5.72% | |
investments in property plant and equipment | -1.20M - | -405K 66.11% | -1.04M 156.54% | -672K 35.32% | -941K 40.03% | -2.65M 181.40% | -5.16M 94.83% | -21.55M 317.76% | -24.23M 12.44% | -14.49M 40.21% | -2.44M 83.15% | |
acquisitions net | 1.69M - | -10.19M 702.07% | 9.36M 191.91% | 49.95K 99.47% | ||||||||
purchases of investments | -537.75M - | -226.04M 57.97% | -213.84M 5.40% | -49.95K 99.98% | ||||||||
sales maturities of investments | 263.05M - | 149.88M 43.02% | 280.53M 87.17% | 288.87M 2.97% | ||||||||
other investing activites | 3.36M - | 171.73K - | 51K 70.30% | |||||||||
net cash used for investing activites | -1.20M - | -405K 66.11% | -1.04M 156.54% | -672K 35.32% | -941K 40.03% | -2.65M 181.40% | -5.16M 94.83% | -291.20M 5,544.49% | -110.58M 62.03% | 61.73M 155.83% | 286.47M 364.06% | |
debt repayment | -220K - | -4.04M - | -4.77M 18.23% | -6.43M 34.67% | -6.36M 1.14% | -10.44M 64.22% | ||||||
common stock issued | 47.91M - | 114.14M 138.25% | 125.97M 10.36% | 133.11M 5.67% | 216.38M 62.56% | 529.33M 144.63% | 638.80M 20.68% | 367.88M 42.41% | 5.06M 98.62% | 10.08M 99.11% | ||
common stock repurchased | -21.61M - | -105.31M 387.41% | ||||||||||
dividends paid | -33.14M - | -5.06M 84.73% | ||||||||||
other financing activites | -8.40M - | -8.50M 1.29% | -8.39M 1.36% | -13.12M 56.39% | -31.70M 141.66% | -31.37M 1.03% | 44.68M 242.41% | 508.43M 1,037.97% | 134.65M 73.52% | |||
net cash used provided by financing activities | -220K - | 47.91M 21,875.91% | 105.74M 120.72% | 117.46M 11.08% | 124.72M 6.18% | 203.27M 62.98% | 493.59M 142.83% | 602.65M 22.09% | 351.39M 41.69% | 396.77M 12.92% | 134.29M 66.15% | |
effect of forex changes on cash | 1.64M - | 8.24M 403.36% | 4.07M 50.65% | -13.66M 435.68% | 20.69M 251.50% | 7.75M 62.57% | -53.49M 790.58% | 38.59M 172.14% | 35.69M 7.51% | -6.01M 116.83% | ||
net change in cash | 4.89M - | 30.74M 527.93% | 69.48M 126.05% | 60.68M 12.67% | 15.02M 75.24% | 82.51M 449.27% | 320.24M 288.12% | -13.59M 104.24% | -138.25M 917.37% | -1.50M 98.92% | -52.60M 3,406.87% | |
cash at beginning of period | 14.54M - | 19.43M 33.68% | 50.17M 158.19% | 119.65M 138.50% | 180.33M 50.72% | 195.35M 8.33% | 277.86M 42.24% | 598.11M 115.25% | 584.52M 2.27% | 446.27M 23.65% | 444.77M 0.34% | |
cash at end of period | 19.43M - | 50.17M 158.19% | 119.65M 138.50% | 180.33M 50.72% | 195.35M 8.33% | 277.86M 42.24% | 598.11M 115.25% | 584.52M 2.27% | 446.27M 23.65% | 444.77M 0.34% | 392.16M 11.83% | |
operating cash flow | 6.31M - | -18.40M 391.65% | -43.47M 136.19% | -60.18M 38.45% | -95.10M 58.03% | -138.80M 45.96% | -175.94M 26.75% | -271.55M 54.34% | -417.65M 53.80% | -495.70M 18.69% | -467.36M 5.72% | |
capital expenditure | -1.20M - | -405K 66.11% | -1.04M 156.54% | -672K 35.32% | -941K 40.03% | -2.65M 181.40% | -5.16M 94.83% | -21.55M 317.76% | -24.23M 12.44% | -14.49M 40.21% | -2.44M 83.15% | |
free cash flow | 5.12M - | -18.81M 467.70% | -44.51M 136.63% | -60.85M 36.73% | -96.04M 57.83% | -141.45M 47.28% | -181.09M 28.03% | -293.10M 61.85% | -441.88M 50.76% | -510.19M 15.46% | -469.80M 7.92% |
All numbers in USD (except ratios and percentages)